You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 1176 to 1200 of about 5889
Next 25
11/22/2018
FDA Grants Fast Track Designation to ONC201 for the Treatment of Adult Recurrent H3 K27M-mutant High-Grade Glioma
SNO 2018: Trials of Two Oncolytic Viruses for Recurrent Malignant Glioma Are Progressing
The impact of traveling distance and hospital volume on post-surgical outcomes for patients with glioblastoma.
Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target
Giving Tuesday! Donate to Musella Foundation
11/20/2018
SNO Highlights
Musella Foundation 2018 Highlights
11/11/2018
Mebendazole and radiation in combination increase survival through anticancer mechanisms in an intracranial rodent model of malignant meningioma.
11/10/2018
The role of erlotinib and the Optune device in a patient with an epidermal growth factor receptor viii amplified glioblastoma.
11/08/2018
Late toxicity in long-term survivors from a phase 2 study of concurrent radiation therapy, temozolomide and valproic acid for newly diagnosed glioblastoma.
Hebrew U Researchers Discover Promising Treatment Against Aggressive Brain Tumors
11/07/2018
ONC201 Investigator Meeting and Clinical Efficacy in H3 K27M-mutant Glioma to be Presented at Society for Neuro-Oncology Conference
11/02/2018
Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine glioma
10/23/2018
A 150-Year-Old Drug Might Improve Radiation Therapy for Cancer
10/17/2018
PVSRIPO (Polio Vaccine) clinical trial now open in 4 brain tumor centers!
10/12/2018
Live Facebook Event about Optune on Oct 22, 2018
Checkpoint Blockade Reverses Anergy in IL-13Ra2 Humanized scFv-Based CAR T Cells to Treat Murine and Canine Gliomas.
Bevacizumab: Is the lower the better for glioblastoma patients in progression?
10/04/2018
Novocure Announces 55 Presentations at European Association of Neuro-Oncology Meeting 2018
09/20/2018
Experimental drug `nothing short of miraculous` for father of 4 with super-rare brain tumor
09/17/2018
Inhibition of Radiation and Temozolomide-Induced Invadopodia Activity in Glioma Cells Using FDA-Approved Drugs.
09/14/2018
Effects of tumor treating fields (TTFields) on glioblastoma cells are augmented by mitotic checkpoint inhibition.
Brain Tumor Webinar Series: Gamma Knife Radiosurgery Sunday, 9/16/18
09/13/2018
Moleculin’s Brain Cancer Drug Candidate Begins Patient Dosing at Clinical Trial Being Conducted at MD Anderson
Researchers make breakthrough in understanding aggressive brain cancer